Brown Advisory
PCVX icon

Brown Advisory’s Vaxcyte PCVX Stock Holding History

Brown Advisory’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.3M Sell
487,017
-24,684
-5% -$1.34M 0.04% 298
2026
Q1 		$29.7M Sell
511,701
-55,224
-10% -$3M 0.05% 267
2025
Q4 		$26.2M Sell
566,925
-110,060
-16% -$4.92M 0.04% 285
2025
Q3 		$24.4M Buy
676,985
+105,046
+18% +$3.48M 0.03% 295
2025
Q2 		$18.6M Buy
571,939
+1,681
+0.3% +$55.1K 0.02% 325
2025
Q1 		$21.5M Buy
570,258
+14,049
+3% +$1.12M 0.03% 306
2024
Q4 		$45.5M Buy
556,209
+112,170
+25% +$11.1M 0.06% 225
2024
Q3 		$50.7M Buy
444,039
+76,822
+21% +$6.92M 0.06% 219
2024
Q2 		$27.7M Buy
+367,217
New +$25M 0.04% 287

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Brown Advisory's PCVX Position: Q2 2026 in Review

Brown Advisory reduced its Vaxcyte (PCVX) stake by 4.8% in Q2 2026, selling an estimated $1.34M and leaving 487,017 shares worth $28.3M. The position accounts for 0.04% of the portfolio, ranked #298.

Brown Advisory first reported a position in PCVX in Q2 2024 and has held it in 9 quarters since. The position peaked at $50.7M in Q3 2024. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Brown Advisory held 487,017 shares of Vaxcyte worth $28.3M as of Q2 2026.
  • Brown Advisory sold 24,684 Vaxcyte shares in Q2 2026, an estimated $1.34M.
  • Vaxcyte made up 0.04% of Brown Advisory's portfolio in Q2 2026, its #298 holding.
  • Brown Advisory first reported a position in Vaxcyte in Q2 2024 and has held it in 9 quarters since.
  • Brown Advisory's Vaxcyte position peaked at $50.7M in Q3 2024.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.